Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Calvert

Showing results (101-110 of 220) with videos related to

Pageof 22
Sort By:
Cancer Chemotherapy and Pharmacology|February 7, 2001
Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumoursH D Thomas, M J Lind, J Ford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10- dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplementS R Wedge, S Laohavinij, G A Taylor, et al.
Journal of Medicinal Chemistry|April 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potencyT R Jones, T J Thornton, A Flinn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Carboplatin and etoposide pharmacokinetics in patients with testicular teratomaD R Newell, R A Eeles, L A Gumbrell, et al.
Analytical Biochemistry|August 1, 1988
Development of an assay for the estimation of N10-propargyl-5,8-dideazafolic acid polyglutamates in tumor cellsE Sikora, D R Newell, A L Jackman, et al.
Otolaryngology|November 1, 1978
A randomized combination chemotherapy trial, with and without adriamycin, in squamous cell carcinoma of the head and neckH J Shaw, L A Price, B T Hill, et al.
Cancer Research|March 1, 1992
Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl-N10-propargyl-5,8-dideazafolic acid: a novel folate-based thymidylate synthase inhibitorB M O'Connor, A L Jackman, P H Crossley, et al.
European Journal of Cancer|January 1, 1981
A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in miceT R Jones, A H Calvert, A L Jackman, et al.
British Journal of Cancer|October 1, 1995
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experienceM E Gore, V Levy, G Rustin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancerD C Talbot, I E Smith, J L Mansi, et al.
Pageof 22

Showing results (101-110 of 220) with videos related to

Sort By:
Pageof 22
Cancer Chemotherapy and Pharmacology|February 7, 2001
Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumoursH D Thomas, M J Lind, J Ford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10- dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplementS R Wedge, S Laohavinij, G A Taylor, et al.
Journal of Medicinal Chemistry|April 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potencyT R Jones, T J Thornton, A Flinn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Carboplatin and etoposide pharmacokinetics in patients with testicular teratomaD R Newell, R A Eeles, L A Gumbrell, et al.
Analytical Biochemistry|August 1, 1988
Development of an assay for the estimation of N10-propargyl-5,8-dideazafolic acid polyglutamates in tumor cellsE Sikora, D R Newell, A L Jackman, et al.
Otolaryngology|November 1, 1978
A randomized combination chemotherapy trial, with and without adriamycin, in squamous cell carcinoma of the head and neckH J Shaw, L A Price, B T Hill, et al.
Cancer Research|March 1, 1992
Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl-N10-propargyl-5,8-dideazafolic acid: a novel folate-based thymidylate synthase inhibitorB M O'Connor, A L Jackman, P H Crossley, et al.
European Journal of Cancer|January 1, 1981
A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in miceT R Jones, A H Calvert, A L Jackman, et al.
British Journal of Cancer|October 1, 1995
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experienceM E Gore, V Levy, G Rustin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancerD C Talbot, I E Smith, J L Mansi, et al.
Pageof 22